| Net Cash Provided by (Used in) Operating Activities |
$7,067 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$5,082 |
USD |
-126% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
4,000,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Shares, Issued |
1,695,351,226 |
shares |
39% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,985 |
USD |
|
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$13,415 |
USD |
-38% |
Q4 2024 |
FY 2024 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
$7,130,936 |
USD |
3.6% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$7,130,936 |
USD |
3.6% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Authorized |
2,000,000 |
shares |
0% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Additional Paid in Capital |
$21,910,960 |
USD |
-1.3% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$822,629 |
USD |
-17% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |